About 1 result found for searched term "DT2216" (0.565 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10423 | DT2216 | PROTAC |
| DT-2216 | ||
| DT2216 is a BCL-XL protein hydrolysis targeting chimera (PROTAC) that ligates and degrades BCL-XL with E3 ubiquitin (E3) ligase. DT2216 is effective against a variety of BCL-XL-dependent leukemias and cancer cells. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
